Health & Fitness
Health and Fitness
Health and Fitness
Tue, September 13, 2011
Mon, September 12, 2011 Geron to Webcast Presentations at Upcoming Investor Conferences
MENLO PARK, Calif.--([ BUSINESS WIRE ])--Geron Corporation (Nasdaq: GERN) today announced that management will present a company overview at two upcoming investor conferences.
- Rodman & Renshaw Annual Global Investment Conference in New York City. David L. Greenwood, Gerona™s President and Chief Executive Officer, will present at 9:35 a.m. EDT on Tuesday, September 13, 2011.
- UBS Global Life Sciences Conference in New York City. Hoyoung Huh, M.D., Ph.D., Gerona™s Executive Chairman, and Stephen M. Kelsey, M.D., Executive Vice President, Head of Research & Development and Chief Medical Officer will present at 10:30 a.m. on Wednesday, September 21, 2011.
The webcasts for the live audio and slide presentations will be available on the aInvestorsa pages of the companya™s website, [ www.geron.com ]. The presentations will be archived for replay and available on the Geron website one hour after conclusion of the live event.
About Geron
Geron is developing first-in-class biopharmaceuticals for the treatment of cancer and chronic degenerative diseases. The company is advancing anti-cancer therapies through multiple Phase 2 clinical trials in different cancers by targeting the enzyme telomerase and with a compound designed to penetrate the blood-brain barrier. The company is developing cell therapies from differentiated human embryonic stem cells for a range of indications, with the first product in a Phase 1 clinical trial for spinal cord injury. For more information, visit [ www.geron.com ].
